Gonorrhea laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 32: Line 32:


===Nucleic Acid Amplification Tests (NAATs)===
===Nucleic Acid Amplification Tests (NAATs)===
*NAAT is FDA-cleared for:
NAATs are the most sensitive test to detect infections.
**Endocervical swabs from women  
Amplified tests include:
**Urethral swabs from men
*Polymerase chain reaction (PCR)
**Urine specimens from both males and females
*Transcription-mediated amplification (TMA)
**Vaginal swabs (some NAATs are clear)
* Strand displacement amplification (SDA)
*NAAT is not FDA-cleared for detection of [[rectal]], [[oropharyngeal]], and [[conjunctival]] gonococcal infection.  
NAAT is FDA-cleared for:
*Some laboratories have met CLIA regulatory requirements and established performance specifications for using NAAT with rectal and oropharyngeal swab specimens that can inform clinical management.  
*Endocervical swabs from women  
 
*Urethral swabs from men
[[DNA]] tests are especially useful as a [[screening test]]. They included the [[ligase chain reaction]] ([[LCR]]) test. [[DNA]] tests are quicker than cultures. Such tests can be performed on [[urine]] samples, which are a lot easier to collect than samples from the [[genital]] area.
*Urine specimens from both males and females
*Vaginal swabs (some NAATs are clear)
NAAT is not FDA-cleared for detection of [[rectal]], [[oropharyngeal]], and [[conjunctival]] gonococcal infection.  
*Some laboratories have met CLIA regulatory requirements and established performance specifications for using NAAT with rectal and oropharyngeal swab specimens that can inform clinical management.
*Antimicrobial susceptibility cannot be determined with these tests. However, the same specimen can be evaluated for ''[[Chlamydia trachomatis]] .


===Non-amplified tests===
Non-amplified tests used for N. gonorrhoeae include:
*DNA probe (e.g., Gen-Probe PACE 2 and Digene Hybrid Capture II)
Antimicrobial susceptibility cannot be determined with these tests. However, the same specimen can be evaluated for ''[[Chlamydia trachomatis]]''.
==Gallery==
==Gallery==



Revision as of 21:36, 25 September 2016

Sexually transmitted diseases Main Page

Gonorrhea Microchapters

Home

Patient Info

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Gonorrhea from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Antibiotic Resistance

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gonorrhea laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gonorrhea laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gonorrhea laboratory tests

CDC on Gonorrhea laboratory tests

Gonorrhea laboratory tests in the news

Blogs on Gonorrhea laboratory tests

Directions to Hospitals Treating Gonorrhea

Risk calculators and risk factors for Gonorrhea laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Laboratory tests

Several laboratory tests are available to diagnose gonorrhea. A doctor or nurse can obtain a sample for testing from the parts of the body likely to be infected (cervix, urethra, rectum, or throat) and send the sample to a laboratory for analysis. Gonorrhea that is present in the cervix or urethra can be diagnosed in a laboratory by testing a urine sample.

Gram stain

Cultures

Culture is the historical standard for detection of Neisseria gonorrhea.

  • Culture test dvantages over non-culture tests include:
    • Low cost
    • Suitable for a variety of specimen sites
    • Antimicrobial susceptibility testing can be performed

Thayer-Martin medium is one example of a medium used for Neisseria gonorrhoeae culture. Cultures can provide a preliminary diagnosis often within 24 hours and a confirmed diagnosis within 72 hours.

Nucleic Acid Amplification Tests (NAATs)

NAATs are the most sensitive test to detect infections. Amplified tests include:

  • Polymerase chain reaction (PCR)
  • Transcription-mediated amplification (TMA)
  • Strand displacement amplification (SDA)

NAAT is FDA-cleared for:

  • Endocervical swabs from women
  • Urethral swabs from men
  • Urine specimens from both males and females
  • Vaginal swabs (some NAATs are clear)

NAAT is not FDA-cleared for detection of rectal, oropharyngeal, and conjunctival gonococcal infection.

  • Some laboratories have met CLIA regulatory requirements and established performance specifications for using NAAT with rectal and oropharyngeal swab specimens that can inform clinical management.
  • Antimicrobial susceptibility cannot be determined with these tests. However, the same specimen can be evaluated for Chlamydia trachomatis .

Non-amplified tests

Non-amplified tests used for N. gonorrhoeae include:

  • DNA probe (e.g., Gen-Probe PACE 2 and Digene Hybrid Capture II)

Antimicrobial susceptibility cannot be determined with these tests. However, the same specimen can be evaluated for Chlamydia trachomatis.

Gallery

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 "Public Health Image Library (PHIL)".

Template:WH Template:WS